SABER II Success Story: SIM COVID
U.S. active-duty military living and working in the USINDOPACOM AOR are at risk of being exposed to COVID-19, which could result in mild or asymptomatic illnesses that could potentially spread amongst an operational force and negatively affect mission readiness. There is limited survey data on the exposure of the U.S. Department of Defense Active-Duty Military Personnel to SARS-CoV-2, the causative agent of COVID-19. There is a need to evaluate various serological platforms by measuring correlation, differences, and agreement of results in paired samples where applicable.
Vysnova supports NAMRU-2 in conducting this research study including the development of the protocol and related SOPs, getting HPRO approval, performing sample collection at sites, storing and transferring samples to different labs, managing data, and completing data analysis. Vysnova provides contracting services, project management, supply procurement and staffing, including Subject Matter Experts.
Three Navy ships in Yokosuka and one Marine corps unit in Japan have agreed to participate in the study – USS Charlottesville, USS Melius, USS Blue Ridge, and the 3rd Marine Logistic Group. We have successfully completed the first round of sample collection with the USS Chancellorsville in February with 105 volunteer participants.
Vysnova provided information about the number of COVID-19 infections among selected USPACFLT forces, thereby helping guide future Force Health Protection measures to mitigate the effects of this disease.